Transplantation of the MSLN ‐deficient Thymus Generates MSLN Epitope Reactive T Cells to Attenuate Tumor Progression
Cancer Science · 2025
DOI: 10.1111/cas.16458 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Science, 2025. Verfasst von Hanchao Gao und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Shenzhen Longhua District Central Hospital, Shenzhen Longhua District Key Laboratory for Diagnosis and Treatment of Chronic…. Hauptthemen laut MEDLINE: Thymus Gland, T-Lymphocytes, GPI-Linked Proteins, Colorectal Neoplasms. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Longhua District Science and Technology Innovation Fund, Natural Science Foundation of Shenzhen Municipality, Shenzhen Longhua District Science and Technology Innovation Fund.
Abstract (Originalsprache)
The development of mesothelin (MSLN) epitope reactive T cells is observed in mice that are immunized with the MSLN vaccine. Engineered T cells expressing MSLN‐reactive high‐affinity TCR exhibit extraordinary therapeutic effects for invasive pancreatic ductal adenocarcinoma in a mouse model. However, the generation of MSLN‐reactive T cells through the introduction of MSLN ‐deficient thymus and the transplantation of the latter as a cure for cancer treatment have not been tested to date. In the present study, the expression of MSLN was mainly identified in medullary thymic epithelial cells (mTECs) but not in hematopoietic cells, cortical thymic epithelial cells (cTECs), endothelial cells, or fibroblast cells in the thymus. The increasement of activated T cells was observed in MSLN‐expressing tumors from MSLN ‐deficient mice, indicating that MSLN‐reactive T cells had developed. Finally, in an AOM‐DSS‐induced mouse model of colorectal cancer (CRC), transplantation of MSLN ‐deficient thymus repressed the progression of CRC, accompanied by an increased number of IFNγ‐expressing T lymphocytes in the tumors. The data from this study demonstrated that ectopic transplantation of MSLN ‐deficient thymus induced MSLN‐specific antitumor responses to MSLN‐expressing tumors, and thus attenuated tumor progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology, Shenzhen Longhua District Central Hospital, Shenzhen Longhua District Key Laboratory for Diagnosis and Treatment of Chronic Kidney Disease, Shenzhen, Guangdong, China.
- Department of Traumatic Orthopedics, Shenzhen Longhua District Central Hospital, Shenzhen, Guangdong, China.
- Department of Medical Laboratory, Shenzhen Longhua District Central Hospital, Shenzhen, Guangdong, China.
- Department of Gynaecology, Shenzhen Longhua District Central Hospital, Shenzhen, Guangdong, China.
ORCID-Profile: Pengfei Chen
Förderung
- Longhua District Science and Technology Innovation Fund
- Natural Science Foundation of Shenzhen Municipality
- Shenzhen Longhua District Science and Technology Innovation Fund
- Guangdong Basic and Applied Basic Research Foundation
- Basic and Applied Basic Research Foundation of Guangdong Province
Zitieren
APA
Gao, H., Wu, H., Ning, L., Zhou, L., Cao, M., Huang, W., Xie, X., Wu, H., Chen, X., Chen, F., Song, J., Deng, K., & Chen, P. (2025). Transplantation of the MSLN ‐deficient Thymus Generates MSLN Epitope Reactive T Cells to Attenuate Tumor Progression. Cancer Science. https://doi.org/10.1111/cas.16458
Vancouver
Gao H, Wu H, Ning L, Zhou L, Cao M, Huang W, et al. Transplantation of the MSLN ‐deficient Thymus Generates MSLN Epitope Reactive T Cells to Attenuate Tumor Progression. Cancer Science. 2025. doi:10.1111/cas.16458
BibTeX
@article{Gao2025,
author = {Gao, Hanchao and Wu, Haiyan and Ning, Lvwen and Zhou, Liying and Cao, Mengtao and Huang, Wenting and Xie, Xihong and Wu, Haidong and Chen, Xiehui and Chen, Feiqiang and Song, Jinqi and Deng, Kai and Chen, Pengfei},
title = {Transplantation of the MSLN ‐deficient Thymus Generates MSLN Epitope Reactive T Cells to Attenuate Tumor Progression},
journal = {Cancer Science},
year = {2025},
doi = {10.1111/cas.16458}
}
EUVIMED